CSI Market
Sign In | Register

Oxford Immunotec Global Plc (OXFD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OXFD Annual Cash Flow →
The quarterly cash flow data below helps track how Oxford Immunotec Global Plc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2020)
9 Months 		(Jun 30 2020) (Mar 31 2020) (Dec 31 2019) (Sep 30 2019)
Operating Activities
Income-30.87
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.01
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-2.26
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.02
Share-based Compensation2.67
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Depreciation Depletion And Amortization Intangible Assets1.44
Noncash Rent Expense0.13
Noncash Interest-0.02
Income taxes-0.19
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable2.59
Increase (Decrease) in Accounts Payable-0.61
Increase (Decrease) in Accrued Liabilities-3.35
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.46
Other Working Capital0.22
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities16.56
Discontinued operations-0.70
Net Cash flow from Operating Activities-12.91
Investing Activities
Capital Expenditures-3.97
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchases Of Intangible Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-4.50
Discontinued operations4.50
Net Cash Flow from Investing Activities-3.97
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-7.63
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-181.56
Proceeds From Exercise Of Share Options And Warrants-
Proceeds Received In Advance Of Share Issuance-
Line Of Credit Discount-
Loss On Extinguishment Of Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations181.37
Interest Received Paid Net-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-7.82
Effect of exchange rate on cash flow-0.59
Discontinued operations4.65
Free Cash Flow-16.88
Total Cash Flow-45.35
4 historic quarters locked

Sign in to unlock the full Oxford Immunotec Global Plc cash flow history.

Sign In Create Free Account

About OXFD Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.